Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 22,000 shares at $485.15 ($10.7M) on 2025-11-26, disclosed to the SEC on 2025-11-26.
Scheduled sale ($10.7M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $483.05 | 513 | $248K | 2.3% |
| 2 | $483.05 | 513 | $248K | 2.3% |
| 3 | $484.20 | 1,727 | $836K | 7.8% |
| 4 | $484.20 | 1,727 | $836K | 7.8% |
| 5 | $485.15 | 2,210 | $1.1M | 10.0% |
| 6 | $485.15 | 2,210 |
| $1.1M |
| 10.0% |
| 7 | $486.23 | 1,923 | $935K | 8.7% |
| 8 | $486.23 | 1,923 | $935K | 8.7% |
| 9 | $487.21 | 3,350 | $1.6M | 15.3% |
| 10 | $487.21 | 3,350 | $1.6M | 15.3% |
| 11 | $488.13 | 1,277 | $623K | 5.8% |
| 12 | $488.13 | 1,277 | $623K | 5.8% |
| Total | $486.07 avg | 22,000 | $10.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-08-06 | $4.3M | — | Filing → |